Speaker Profile

PHD, VP, Clinical and Scientific Affairs, Bionano Genomics

Biography
Alex Hastie has a PhD in Molecular and Cellular Biophysics and Biochemistry from Roswell Park Cancer Institute. He has received postdoctoral training in biochemistry at the Max Planck Institute for Biochemistry in Munich, Germany. He has spent over a decade with Bionano Genomics helping to design and develop core applications for optical genome mapping in genomics and epigenetics. Dr. Hastie is a lover of technology and believes that better genomics technology can improve the quality of life for people everywhere in the world.

Talk
Transforming Genome Visualization Interpretation with Optical Genome Mapping


 Session Abstract – PMWC 2022 Silicon Valley


Sequencing technologies are continuously improving, making it easier to obtain more in-depth molecular information than ever before. Emerging single-cell multi-omics sequencing technologies allow the capture of multiple modalities from a cell, including its epigenome, transcriptome, epitranscriptome, and proteome. This allows research into the heterogeneity of many biological mechanisms, and insights into complex molecular mechanisms that underpin disease.

Sessions:

  • 4th Generation Sequencing Technologies & Genome Mapping Systems
    - Barrett Bready, Nabsys
    - Alka Chaubey, Bionano Genomics
    - Eli Glezer, Singular Genomics
  • Long-Read Sequencing Technologies
    - Steve Turner, PacBio
  • Single Cell Genomics
    - Michael Schnall-Levin, 10x Genomics
  • Spatial Transcriptomics
    - Jason T. Gammack, Resolve Biosciences
  • Pathogen Identification
    Session Chair: Charles Chiu, UCSF
    - Philip Stevens, Noscendo
  • Metagenomics and Microbial Profiling
    - Amrie Grammer, Ampel BioSolutions
  • ML/AI for Diagnosis & Prognosis
    - Todd Dickinson, Arc Bio
  • Modern Technologies for Pathogen Identification + AI
    Session Chair: Sivan Bercovici, Karius Dx
  • Novel SBS Methodology
    - Josh Lauer, Ultima Genomics
  • Proteogenomics
    - Nigel Beard, Encodia
  • Advances Proteomics - Stratifying Cardiovascular Risk to Decrease Cost of Care
    Session Chair: Roy Smythe, SomaLogic
    - Adrian Lee, UPMC
    - Jamie Bauersmith, UPMC
  • Leveraging Immune System Diagnostics to Improve Disease Outcomes
    Session Chair: Kathy Kamath, Serimmune, Inc
    - Noah Nasser, Serimmune, Inc
    - Sasha Tabachnikova, Yale
  • Evolving Alzheimer’s Disease Therapeutics with Neuro Diagnostic Therapies (PANEL)
    Session Chair: Kevin Hrusovsky, Quanterix
    - Charlotte Teunissen, Amsterdam UMC
    - Henrik Zetterberg, University of Gothenburg
    - Nicholas Ashton, University of Gothenburg
  • PMWC Showcase (NCI)
    - Michael Cardone, Eutropics Pharmaceuticals
    - Robert Meltzer, Fluent BioSciences
    - Cynthia Taylor Lawley, Olink Proteomics
    - Niro Ramachandran, Akoya Biosciences
    - Asim Siddiqui, Seer